Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003051:Cochlea; D004311:Double-Blind Method; D005260:Female; D011345:Fenofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006309:Hearing; D006311:Hearing Disorders / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007759:Labyrinth Diseases / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011422:Propionates / Q000627:therapeutic use*; D011897:Random Allocation; D014722:Vestibule, Labyrinth
D000960:Hypolipidemic Agents; D011422:Propionates; C006012:fenofibric acid; D011345:Fenofibrate